Mat represents public and private national and multinational companies in all aspects of buy-side and sell-side, stock, asset, merger, acquisition and divestiture transactions, with specific experience in managing cross-border transactions.

Mat also advises companies on integral corporate matters, such as the preparation, review, and negotiation of business-critical commercial agreements, management of internal restructurings, and general corporate and governance matters.

Clients that Mat represents span across a variety of industries, including health care providers, pharmaceutical, science and biotechnology, food and beverage, water treatment and other heavy industries, software and technology, communications, retail and consumer, as well as advertising companies.

Before attending law school, Mat held marketing and product management positions in the life sciences manufacturing and distribution sector.

Life Science Transactions

• Represented an NYSE-listed multinational leading global provider of life science products in an initial strategic investment and subsequent acquisition of a French life sciences instrumentation company.
• Represented a Canadian-listed pharmaceutical company in the strategic acquisition of the operations and global products rights to a leading lice and scabies treatment product.
• Represented a Danish-listed pharmaceutical company in the acquisition of the operations and global products rights to a diagnostic skin test for the evaluation of penicillin allergy.
• Represented an NYSE-listed multinational leading global provider of life science products in the divestiture of a non-core-asset subsidiary.
• Represented the US subsidiary of a world leader in food, environment, pharmaceutical, and cosmetic product testing in the acquisition of an environmental testing, monitoring, and analysis company.
• Represented an NYSE-listed leading manufacturer of water treatment products in the strategic divestiture of its dialysis filter product line.
• Represented an NYSE-listed leading manufacturer of water treatment products in the strategic divestiture of its dialysis concentrates product line.
• Represented a medical monitoring products company in several debt and equity financing transactions.

Health Care Transactions

• Represented an NYSE-listed retail pharmacy chain in the acquisition of a major regional retail pharmacy chain in the Pacific Northwest.
• Represented an NYSE-listed retail pharmacy chain in the acquisition of certain critical retail equipment.
• Represented several dentist systems and dentist practices in the sale of clinical and non-clinical assets to a private equity platform company.
• Represented a leading pharmacy and telepsychiatry provider in the acquisition of a Canadian long-term care and retail pharmacy software developer.
• Represented a leading provider of nurse practitioner services in the sale of substantially all of its assets.
• Represented the nation’s largest network of adult day health centers in a $20 million add-on round of equity financing.
• Represented a private equity fund in the platform acquisition of a chain of 20 physical therapy treatment centers.
• Represented an HCV specialty pharmacy in add-on acquisitions of additional specialty pharmacy locations.

Hospital Affiliations

• Advised Summit Health in its affiliation with WellSpan Health.
• Advised Hanover HealthCare Plus, Inc. in its affiliation with Pinnacle Health System/UPMC.

Food and Beverage

• Represented an NYSE-listed multinational food company in a strategic acquisition of an organic soups, broths, and non-dairy milk company.
• Represented an NYSE-listed multinational food company in a strategic divestiture of its organic nuts business.
• Represented an NYSE-listed multinational food company in a strategic divestiture of its baby food business.
• Represented a NASDAQ-listed specialty foods company in a divestiture of its pancake and waffle mix business to a private equity fund.
• Represented a full-line foodservice distributor in the sale of substantially all of its assets to a strategic buyer.
• Represented a private equity fund in the leveraged buyout of the nation’s largest provider of waffle mix.

Water Treatment

• Represented an NYSE-listed leading manufacturer of water treatment products in numerous cross-border strategic stock and asset acquisitions and divestitures, including 14 stock acquisitions, 12 asset acquisitions, and 4 divestitures of non-core assets.

Other Industries

• Represented a private equity fund in the platform acquisition of a multinational data mining company.
• Represented the portfolio company of a private equity fund in the acquisition of a data Polish analysis software company.
• Represented a multifaceted telecommunications company in the divestiture of 96 communications towers in the Midwest.
• Represented an international adhesives company in the acquisition of substantially all of the assets of a flooring and floor preparation business.
• Represented an international commercial seating manufacturer in the sale of substantially all of its assets to a private equity fund.
• Represented a recruitment consulting, analyses, assessment, and optimization company in the sale of all of its assets to a strategic buyer.
• Represented a national outdoor advertiser in the asset acquisition of certain strategic advertising licenses.